Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-24-007731
Filing Date
2024-11-29
Accepted
2024-11-27 21:26:45
Documents
52
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q abti_10q.htm   iXBRL 10-Q 692869
2 CERTIFICATION abti_ex311.htm EX-31.1 12800
3 CERTIFICATION abti_ex312.htm EX-31.2 12728
4 CERTIFICATION abti_ex321.htm EX-32.1 7623
10 abti_10qimg2.jpg GRAPHIC 2721
  Complete submission text file 0001477932-24-007731.txt   3303225

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA abti-20240930.xsd EX-101.SCH 35917
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE abti-20240930_lab.xml EX-101.LAB 221075
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE abti-20240930_cal.xml EX-101.CAL 42391
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE abti-20240930_pre.xml EX-101.PRE 184968
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE abti-20240930_def.xml EX-101.DEF 102010
55 EXTRACTED XBRL INSTANCE DOCUMENT abti_10q_htm.xml XML 302827
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 333-156091 | Film No.: 241512952
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)